Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.260 | 1.260 | 0.000 |
Stocks | 98.740 | 98.740 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 18.111 | 11.967 |
Price to Book | 4.187 | 1.757 |
Price to Sales | 1.719 | 1.027 |
Price to Cash Flow | 13.878 | 7.245 |
Dividend Yield | 2.926 | 4.826 |
5 Years Earnings Growth | 7.067 | 9.311 |
Name | Net % | Category Average |
---|---|---|
Industrials | 31.970 | 14.190 |
Consumer Defensive | 29.390 | 13.962 |
Consumer Cyclical | 10.270 | 10.411 |
Healthcare | 8.570 | 9.864 |
Financial Services | 8.410 | 21.028 |
Technology | 6.020 | 4.165 |
Real Estate | 2.460 | 3.850 |
Communication Services | 1.660 | 5.143 |
Basic Materials | 1.260 | 7.369 |
Number of long holdings: 38
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Unilever | GB00B10RZP78 | 8.13 | 51.68 | -0.12% | |
Relx | GB00B2B0DG97 | 8.03 | 3,491.00 | -0.34% | |
Diageo | GB0002374006 | 7.53 | 2,594.5 | -0.48% | |
Reckitt Benckiser | GB00B24CGK77 | 5.69 | 4,388.0 | -0.72% | |
Bunzl | GB00B0744B38 | 4.78 | 2,958.0 | +0.34% | |
Experian | GB00B19NLV48 | 3.93 | 3,679.0 | +0.80% | |
Smiths Group | GB00B1WY2338 | 3.31 | 1,705.00 | -0.58% | |
Intertek | GB0031638363 | 3.23 | 4,786.0 | -1.24% | |
GSK plc | GB00BN7SWP63 | 3.07 | 1,615.00 | -0.37% | |
Smith & Nephew | GB0009223206 | 2.98 | 1,008.50 | -1.80% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
T Bailey Dynamic Inst Acc | 72.82M | 4.07 | -0.58 | 4.53 | ||
T Bailey Dynamic Inst Inc | 25.71M | 0.46 | -0.68 | 4.20 | ||
GB00BMD8NV62 | 67.74M | -16.66 | - | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review